NS Pharma Announces Strategic Alliance with Boston Children’s Hospital to Develop New Therapies for Rare Diseases
NS Pharma, Inc. (NS Pharma) announced today that its parent company, Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), headquartered in Kyoto, Japan, has finalized a strategic partnership with Boston Children's Hospital (Boston Children's) (Headquarters: Boston, Massachusetts, United States), to support the research and development of innovative therapies for rare diseases.Nippon Shinyaku and Boston Children's will leverage […]